Embed
Email

Psychiatry

Document Sample

Shared by: linzhengnd
Categories
Tags
Stats
views:
1
posted:
11/12/2011
language:
English
pages:
4
Psychiatry

10/31/01

Dr. Lewis

Chris T. for Aaron P.



So what do we really know about our unmet needs? Despite advances in out treatment,

the actually pathophysiology of major depression continues to elude us. Only about 1/3 of

patients achieve full remission. The pharmaceutical companies tell you a lot of ½ truths. You

have to be very skeptical about what drug reps tell you. They will try to up play the efficacy of

their drug. They will tell you 70% of your depressed patients will respond to their product. Only

25-35% of patients actually have true remission.



Remission is very different from response. Remission is defined as a Hamilton

depression score of 7 or less. Many patients are only partial responders. A patient who has a 50%

reduction of their Hamilton score is considered a responder in clinical trials. These patients will

come back to you and say they are still not feeling good. This leads to a tremendous amount of

frustration on the part of phycisians out there working with psychotropic drugs.



In 1990 mood disorders were the 4th leading cause disability, and in 2020 it will be 2nd

only to ischemic heart disease. Antidepressant nonresponders are the biggest problem for us.



As far as clinical trials go, patients with a response are count in the group that does well.

These patients really are not going to be satisfied. They're still suffering in subsyndromic kind of

way from their depression. We really want patients to acheive remission. Remission rates are

really not so good. The highest rates of remission are seen with the oldest drugs, tricyclics and

MAOIs. They are close to 45%. There is a 35% remission with SNRIs, which is Effexor. All the

SSRIs, Prozac and Paxil and Zoloft, the most widely used and frequently prescribed agents, have

a remission rate of 25%. The least effective agents are used the most frequently and the most

effective agents are used the least frequently. Tolerability gets worse as you go to drugs that are

more effective.



We should be very suspicious of patients who relapse very quickly when they are

compliant with antidepressant treatment. They are at high risk for possibly having bipolar

disorder. They probably need chronic maintenence management. Relapse and recurrance are

predictive of whether patients need chronic maintanence. Patients who have had 1 episode of

depression are 50% likely to have a second, patients who have had 2 episodes are 70% likely to

have a 3rd, patients who have 3, it's a foregone conclusion that they are going to have a 4th.



We did a survey in the area on primary care prescribing practices and got some

interesting results. Doctors were asked to rank disease states that are commonly treated occording

to which ones they enjoy seeing and which ones they don't enjoy seeing. Patients with depression

or anxiety were generally at the bottom of the list. These patients are resistant to treatment and

refractory to treatment. They don't get better and the keep coming back. Doctors don't like

patients like this, they like patients who get better.



Part of the problem of resistance and refractoriness is in diagnosis and detection. If the

diagnosis is cleaned up a bit, we can reduce the rate of resistance and refractoriness to about 8%

or so. And 8% is about the amount of depressed patients who end up getting ECT, maybe slightly

more.









1

Case 1



Forty seven year old latin-american male with no previous psychiatric history. Presents to

PCP (primary care physician) with complaints of depressed mood, fatigue, difficulty with

concentration, impaired sleep, early morning awakening, and loss of libido.



Upon examination the PCP noted poor eye contact, marked latency of response, and

marked hand-wringing. He denies suicidal ideation and admits the illness has impaired his ability

to work.



Diagnosis of major depression, single episode was made by PCP and patient was referred

to a social worker for psychotherapy once weekly. He was also given 3 antidepressant trials with

good therapeutic doses for 4 weeks (6 weeks would be better) each of Paxil, Zoloft and

Wellbutrin. This is reasonable, but going from one SSRI to another may not be the best idea,

trying another group would maybe have been better.



Despite treatment during the 12 week period, the patient deteriorates, becomes frustrated,

and becomes hopeless to the prospect of ever being well again. The PCP now refers him to a

psychiatrist for help. On psychiatric evaluation, the same things are noted, poor eye contact,

hand-wringing, and latency of response. He was very depressed, he spoke in a faint voice,

complained that food was tasting bland. He described guilt over failures at work. He complained

of loss of interest in his future and reports taking a leave of absence from his job.



At this point would you change the diagnosis? Maybe try some different medication,

TCAs or MAOIs. We changed his diagnosis. He does have major depression, single episode,

severe, without any psychotic features, but he fits into the melancholic subtype. This is the least

frequently seen subtype in the primary care setting. They generally go to some mental health

treatment more directly.



Dual-acting antidepressants or combination treatment is far more effective in melancholic

depression than SSRIs. We treated him with venlafaxine and he had a remission of his illness by

week 6, with a Hamilton score of 7. What we really had was an incomplete diagnosis for this

patient.



In regard to the psychotherapy, with depression there is a cut off with a Hamilton score of

20. This guy had a Hamilton score over 20 and did not do well with the psychotherapy. With

Hamilton scores below 20, patients generally do pretty well with therapy.



Case 2



Twenty three year old single white male presents to his PCP complaining of increasingly

depressed mood, accompanied by severe insomnia, marked agitation, anxiety, as well as difficulty

organizing and controlling his thought processes. His girlfriend claims that he is not himself. He

is very angry, irritable and sleepless. He is spending a great deal of time on office work but not

being very productive, he is staying up late but not getting things accomplished. No prior

psychiatric history. Mother was hospitalized 3x in the past for "nervous breakdowns". This is an

important clue.



The diagnosis by his PCP was agitated depression, which is not a true diagnosis, but we

do see patients with depression of an agitated type. His treatment plan was to use Prozac. After 5

days of therapy, the patient's girlfriend phoned the physician reporting the patient had increasing





2

insomnia, hostility and threatening behavior. The patient agrees to undergo psychiatric

hospitalization.



The average age of onset of major depression is 28, so it is suspicious whenever someone

this young comes in with depression. Anyone under the age of 25, you should be very suspicious

of other things, like drug abuse and bipolar. The average age of onset of bipolar disorder is late

teens-early twenties, and it is autosomal dominant inheritance.



SSRIs make bipolar patients worse. They can make them highly suicidal and homicidal.

You have to be very suspicious that a patient who becomes increasingly agitated on an SSRI, that

maybe you've missed the diagnosis.



On admission to the hospital he is found to be depressed, but is very irritable. He is very

hostile, exhibits marked psychomotor agitation, complains of racing thoughts and now we get the

suicidal ideation. We now have a patient that was started on Prozac and became suicidal. If you

are not careful who you give Prozac to, you may accelerate someone's bipolar illness and they

may become quite suicidal or homicidal.



His real diagnosis was bipolar disorder type 1 with mixed state. Mixed because he is

manic and depressed at the same time. The Prozac was discontinued and he was started on a

mood stabilizer, olanzapine. He was discharged after 6 days and returned to work and was doing

very well on the mood stabilizer.



The family history of nervous breakdowns was initially missed, which should have been

a tip-off for bipolar disorder. The early age of onset was missed which also points to bipolar

disorder. Global insomnia and agitation are also common in bipolar disorder.



Case 3



Thirty four year old married white female complains to her PCP of depressed mood,

fatigue, worry, insomnia, loss of appetite and weight loss. Symptoms emerging over the last 4

months. Reports that this is her third time since age 28 that she has felt this poorly. She reports

that despite multiple antidepressant trials she has never achieved more than a partial

improvement.



Diagnosis made by PCP is major depression recurrent, with poor interepisode recovery.

This is a very reasonable diagnosis. Patient reports that Prozac had helped the most in the past, so

she was started on Prozac 20mg a day and escalated to 60mg a day over the course of 5 weeks.

She experienced a marginal benefit from this.



She was sent for psychiatric evaluation and presents unchanged, and her Hamilton score

was 20. We see this patient as being treatment resistant. She was continued on Prozac and

olanzapine was added. The patient had reduced anxiety and increased sleep by day 2. Remission

is achieved and maintained after day 18 and she goes down to a Hamilton score of 6.



This case was really a treatment problem. Any SSRI and olanzapine are effective in the

treatment resistant patient. These are patients who have failed 2 antidepressant trials from 2

different classes. Polypharmacy is not such a bad word in psychiatry.



Proper diagnosis and medication selection are critical to good patient care.







3

Exam Review



-Know classes of medicines, there are a few little cases on the exam, the diagnosis is not given

away. Symptoms are given and you have to put together the diagnosis and what medication

would be a good choice.

-Know what categories drugs belong to.

-Know what are mood stabilizers, what are atypical antipsychotics, conventional antipsychotics,

potencies of conventionals.

-Know what's an SSRI, common side effects (sexual dysfunction).

-What drugs are TCAs, MAOIs, and other atypical antidepressants.

-Dr. Kass did not write any questions.

-Dr. Shaw will have some questions on psychotherapy.

-There's no matching, just T-F and MC.

-Make sure you read the pearls in the book.

-Look at the old exams.

-Read the questions very carefully, even if they look like old questions, they may not be.









4



Related docs
Other docs by linzhengnd
i-Health
Views: 0  |  Downloads: 0
State employees recall events of September 11
Views: 7  |  Downloads: 0
0804050421330_2110
Views: 4  |  Downloads: 0
Listino2009 - Meetup
Views: 0  |  Downloads: 0
TwoSurveyCalculator
Views: 0  |  Downloads: 0
Guidelines.xlsx
Views: 0  |  Downloads: 0
APPALACHIA AND THE OZARKS
Views: 2  |  Downloads: 0
Proliferation Studies
Views: 0  |  Downloads: 0
By registering with docstoc.com you agree to our
privacy policy

You are almost ready to download!

You are almost ready to download!